AP -- Sanofi-Aventis SA began work Tuesday on a $477 million plant that is to be devoted to production of the world’s first vaccine against dengue fever, a public health threat for some two-fifths of the worlds population.
AP -- Sanofi-Aventis SA began work Tuesday on a $477 million plant that is to be devoted to production of the world’s first vaccine against dengue fever, a public health threat for some two-fifths of the worlds population.
